For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Human Genome Sciences, Inc.

USPTO Granted Patents = 676

CIPO Patents = 8

EPO Patents = 21

Trademarks = 4

Forward Citations = 7,837

Loading Chart...

Loading Chart...

227 inventors (with patents filed for the assignee):

Craig A Rosen (312 out of 329 patents)

Steven M Ruben (253 out of 266 patents)

Jian Ni (180 out of 190 patents)

4. Guo-Liang Yu (101 out of 142 patents)

5. Reiner L Gentz (79 out of 82 patents)

6. Mark D Adams (72 out of 84 patents)

7. Henrik S Olsen (59 out of 61 patents)

8. Haodong Li (55 out of 60 patents)

9. Reinhard Ebner (54 out of 55 patents)

10. Ying-Fei Wei (53 out of 56 patents)

11. Reiner L Gentz (53 out of 59 patents)

12. Patrick J Dillon (52 out of 62 patents)

13. Yi Li (51 out of 62 patents)

14. Paul A Moore (38 out of 79 patents)

15. Daniel R Soppet (38 out of 40 patents)

Core Competencies:

Vascular Endothelial Growth Factor 2

Albumin Fusion Proteins

B Lymphocyte Stimulator Protein

Neutrokine-Alpha Antibodies

Tumor Necrosis Factor Receptors

Intracellular Sialylation Pathways

Human G-Protein Chemokine Receptor

Human Neuronal Attachment Factor-1

G-CSF-Albumin Fusion Proteins

Methods of Diagnosing Hodgkin's Lymphoma

Death Domain Containing Receptor 4 Antibodies

Methods of Reducing Toxicity

676 patents: Sort by Forward Citations

1. 9403905 - Vascular endothelial growth factor 2 (2016-08-02),

2. 9296809 - Albumin fusion proteins (2016-03-29),

3. 9221896 - Albumin fusion proteins (2015-12-29),

4. 9187548 - Antibodies that immunospecifically bind to B lymphocyte stimulator protein (2015-11-17),

5. 9168286 - Methods and compositions for use in treatment of patients with autoantibody positive disease (2015-10-27),

6. 8993517 - Albumin fusion proteins (2015-03-31),

7. 8969538 - Albumin fusion proteins (2015-03-03),

8. 8946156 - Albumin Fusion Proteins (2015-02-03),

9. 8937169 - Human G-protein chemokine receptor HSATU68 (2015-01-20),

10. 8784809 - Vascular endothelial growth factor 2 (2014-07-22),

11. 8546105 - Engineering intracellular sialylation pathways (2013-10-01),

12. 8518389 - Methods of inhibiting proliferation or immunoglobulin production of B cells using human tumor necrosis factor receptor TR-17 polypeptides (2013-08-27),

13. 8513189 - Albumin fusion proteins (2013-08-20),

14. 8410248 - HWBAO62 polypeptides (2013-04-02),

15. 8372948 - 12 human secreted proteins (2013-02-12),

Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company that specializes in the discovery and development of novel drugs to treat various diseases. HGS is committed to improving patients' lives by advancing the understanding and treatment of human genetics. With a focus on genomics research, they strive to discover innovative therapies for conditions such as cancer, infectious diseases, and autoimmune disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

676 Patents

#1 in Rockville, MD

#7 in Maryland

#717 in US

#1,439 in the World

Rockville, MD, United States of America

Human Genome Sciences, Inc.

Forward Citations = 7,837

227 inventors:

Craig A Rosen (312 out of 329 patents)

Steven M Ruben (253 out of 266 patents)

Jian Ni (180 out of 190 patents)

4. Guo-Liang Yu (101 out of 142 patents)

5. Reiner L Gentz (79 out of 82 patents)

Please report any incorrect information to support@idiyas.com

Loading…